NCT00969046View on ClinicalTrials.gov

Dose-Escalation Study in Advanced Colon Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Colon Cancer
Interventions
DRUG

EPO906 (patupilone)

Trial Locations (6)

Unknown

Novartis Investigative Site, Hradec Králové

Novartis Investigative Site, Prague

Novartis Investigative Site, Saint-Herblain

Novartis Investigative Site, Toulouse

Novartis Investigative Site, Barcelona

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY